Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance - Scorecard - MDSpire

Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance

  • By

  • Giovanni Donato Aquaro

  • Carmelo De Gori

  • Giulia Grilli

  • Roberto Licordari

  • Andrea Barison

  • Giancarlo Todiere

  • Umberto Ianni

  • Matteo Parollo

  • Crysanthos Grigoratos

  • Luca Restivo

  • Antonio De Luca

  • Lorenzo Faggioni

  • Dania Cioni

  • Gianfranco Sinagra

  • Gianluca Di Bella

  • Emanuele Neri

  • January 24, 2023

  • 0 min

Share

Clinical Scorecard: The Dark Papillary Muscle Sign: A New Prognostic Indicator in Cardiac Magnetic Resonance Imaging

At a Glance

CategoryDetail
ConditionPapillary muscle abnormalities in patients with ventricular arrhythmias and preserved left ventricular function
Key MechanismsSystolic hypointensity (Dark-Paps) of papillary muscles on early post-contrast cine CMR indicating tissue abnormalities; association with mitral valve prolapse and mitral annular disjunction
Target PopulationPatients with frequent premature ventricular complexes (PVC) or non-sustained ventricular tachycardia (NSVT) with preserved LV systolic function and no prior cardiac disease
Care SettingCardiac magnetic resonance imaging in specialized cardiology centers

Key Highlights

  • Papillary muscles play a critical role in mitral valve function and left ventricular mechanics.
  • Dark-Paps sign is identified as systolic hypointensity of both papillary muscles on early post-contrast cine CMR images.
  • Dark-Paps is associated with mitral valve prolapse and may have prognostic implications in patients with ventricular arrhythmias.

Guideline-Based Recommendations

Diagnosis

  • Use early post-contrast cine steady-state free precession (SSFP) CMR imaging to assess papillary muscle morphology and signal intensity.
  • Evaluate papillary muscles for systolic hypointensity relative to the interventricular septum to identify Dark-Paps.
  • Assess mitral valve anatomy for prolapse and mitral annular disjunction using long-axis and para-axial CMR views.

Management

  • Consider the presence of Dark-Paps and associated mitral valve abnormalities in risk stratification of patients with ventricular arrhythmias.
  • Optimize ECG gating with short-term antiarrhythmic therapy before CMR in patients with frequent PVCs or ventricular bigeminism to improve image quality.

Monitoring & Follow-up

  • Monitor patients with Dark-Paps for potential progression of ventricular arrhythmias and mitral valve dysfunction.
  • Follow-up imaging may be warranted to assess changes in papillary muscle morphology and function.

Risks

  • Patients with papillary muscle abnormalities and Dark-Paps may have increased risk of ventricular arrhythmias.
  • Mitral annular disjunction associated with papillary muscle abnormalities may predispose to myocardial fibrosis and arrhythmic events.

Patient & Prescribing Data

Patients with frequent PVCs or NSVT undergoing CMR evaluation

Short-term oral antiarrhythmic agents administered prior to CMR can optimize ECG triggering and image acquisition quality.

Clinical Best Practices

  • Perform comprehensive CMR including early post-contrast cine SSFP and late gadolinium enhancement sequences for detailed papillary muscle and mitral valve assessment.
  • Measure radial angles, maximal diameter, and signal intensity of anterolateral and posteromedial papillary muscles systematically.
  • Use a multidisciplinary approach integrating imaging findings with clinical arrhythmia data for prognostic evaluation.

References

Original Source(s)

Related Content